cyproterone acetate has been researched along with Coronary Heart Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jespersen, J; Schwarz, H; Sidelmann, JJ; Skouby, SO; Vitzthum, F | 1 |
| Chen, KC; Chyau, CC; Hsieh, CL; Hsieh, HM; Huang, CN; Peng, CC; Peng, CH; Peng, RY; Wang, HE | 1 |
| Boerrigter, PJ; Schram, JH; The, TY | 1 |
| Schneider, HP | 1 |
1 review(s) available for cyproterone acetate and Coronary Heart Disease
| Article | Year |
|---|---|
The role of antiandrogens in hormone replacement therapy.
Topics: Androgen Antagonists; Biological Availability; Body Weight; Chemistry, Pharmaceutical; Cognition; Coronary Disease; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Osteoporosis, Postmenopausal; Patient Selection; Progesterone Congeners; Treatment Outcome | 2000 |
2 trial(s) available for cyproterone acetate and Coronary Heart Disease
| Article | Year |
|---|---|
Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
Topics: Adult; Age Factors; Coronary Disease; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Risk Factors; Serine Endopeptidases | 2010 |
Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
Topics: Administration, Cutaneous; Administration, Oral; Climacteric; Coronary Disease; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoprotein(a); Liver Function Tests; Middle Aged | 1995 |
1 other study(ies) available for cyproterone acetate and Coronary Heart Disease
| Article | Year |
|---|---|
Antiandrogenic therapy can cause coronary arterial disease.
Topics: Aged; Androgen Antagonists; Apolipoprotein A-I; Apolipoprotein A-II; Biomarkers; Cholesterol, HDL; Coronary Disease; Cyproterone Acetate; Electrocardiography; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Risk Factors; Triglycerides | 2005 |